article thumbnail

LimFlow Limits Limb-Threatening Ischemia

CardiacWire

Late-breaking second year results from the PROMISE II trial showed that the LimFlow system achieved strong outcomes for avoiding amputations and promoting limb salvage among “no-option” patients with chronic limb-threatening ischemia (CLTI). Ischemia in the treated limb also decreased significantly, with 65.8%

article thumbnail

Adipsin improves diabetic hindlimb ischemia through SERPINE1 dependent angiogenesis

Cardiovascular Diabetology

Adipsin (complement factor D, CFD), as the first described adipokine, is well-known for its regulatory effects in diabetic cardiovascular complications. However, its role in diabetic hind-limb ischemia was not.

article thumbnail

Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction

Cardiovascular Diabetology

Mitochondria play a central role in cellular energy metabolism, and their dysfunction is increasingly recognized as a critical factor in the pathogenesis of diabetes-related cardiac pathophysiology, including vu.

article thumbnail

HORNBILL: BI 764524 Meets Safety Endpoints in Diabetic Macular Ischemia

HCPLive

BI 764524 was well tolerated following intravitreal administration of single and multiple doses in the phase 1/2a trial, with signs pointing to early efficacy.

article thumbnail

Immunoglobulin-mediated Cardiac Protection from Ischemia/Reperfusion Injury in Diabetic Rats is associated with Endothelial Nitric Oxide Synthase/Glucose Transporter-4 Signaling Pathway

Journal of Cardiovascular Pharmacology

The role of intravenous immunoglobulin in protecting the diabetic heart from ischemia/reperfusion (I/R) injury is unclear. Hearts isolated from adult diabetic and non-diabetic Wistar rats (n=8 per group) were treated with intravenous immunoglobulin (IVIG) either two hours before euthanasia, before ischemia, or at reperfusion.

article thumbnail

ICAM1 blockade improves ischemic muscle reperfusion in diabetic mice

Cardiovascular Diabetology

Chronic Limb-Threatening Ischemia (CLTI) represents the most advanced stage of Peripheral Artery Disease (PAD) and is associated with dire prognosis, characterized by a substantial risk of limb amputation and.

article thumbnail

Ophthalmology Month in Review: May 2024

HCPLive

Sadda, MD, and promising data from studies on geographic atrophy, diabetic macular ischemia, diabetic retinopathy, and AMD. This month-in-review features an exclusive interview with Srinivas R.